The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

Khanna, Chand, Wan, Xiaolin, Bose, Seuli, Cassaday, Ryan, Olomu, Osarenoma, Mendoza, Arnulfo, Yeung, Choh, Gorlick, Richard +2 more·2004·Nature Medicine

Cited by (707)

Items 301–400 of 707

  1. Ez-Metastasizing: The Crucial Roles of Ezrin in Metastasis
    Rand Gabriel M. Buenaventura, Glenn T Merlino, Yanlin Yu · 2023 · Cells
  2. miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression
    Nengwang Yu, Shuai Fu, Yubao Liu, Zhonghua Xu, Yi Liu, Junwen Hao, Baocheng Wang, Aimin Zhang · 2015 · Journal of Experimental & Clinical Cancer Research
  3. Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment
    Leena Heiska, Maria Melikova, Fang Zhao, Ichiko Saotome, Andrea I. McClatchey, Olli Carpén · 2011 · Oncogene
  4. Malignant transformation of 293 cells induced by ectopic expression of human Nanog
    Yanli Lin, Zheng‐Bin Han, Fuyin Xiong, Liyuan Tian, Xiaojie Wu, Shi-Wei Xue, Yanrong Zhou, Jixian Deng, Hongxing Chen · 2011 · Molecular and Cellular Biochemistry
  5. Epigenetic and Epigenomic Mechanisms Shape Sarcoma and Other Mesenchymal Tumor Pathogenesis
    Idriss M. Bennani-Baı̈ti · 2011 · Epigenomics
  6. Effect of Curcumin and Its Derivates on Gastric Cancer: Molecular Mechanisms
    Afsane Bahrami, Gordon A. Ferns · 2020 · Nutrition and Cancer
  7. Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9
    Beibei Zhou, Jun Leng, Hu Meng, Li Zhang, Zhan Wang, Dongying Liu, Xiaoling Tong, Beibei Yu, Yi Ping Hu, Chaohua Deng et al. · 2009 · Leukemia Research
  8. Ezrin Expression as a Prognostic Marker in Colorectal Adenocarcinoma
    Marcelo Patara, Érika Maria Monteiro Santos, Renata de Almeida Coudry, Fernando Augusto Soares, Fabio Oliveira Ferreira, Benedito Mauro Rossi · 2011 · Pathology & Oncology Research
  9. Intracellular Theileria annulata Promote Invasive Cell Motility through Kinase Regulation of the Host Actin Cytoskeleton
    Min Ma, Martin Baumgartner · 2014 · PLoS Pathogens
  10. Phosphorylation of Ezrin by Cyclin-Dependent Kinase 5 Induces the Release of Rho GDP Dissociation Inhibitor to Inhibit Rac1 Activity in Senescent Cells
    Hi-Su Yang, Philip W. Hinds · 2006 · Cancer Research
  11. A role for ezrin in a neglected metastatic tumor function
    Stefano Fais · 2004 · Trends in Molecular Medicine
  12. Role of αVβ3 in Prostate Cancer: Metastasis Initiator and Important Therapeutic Target
    Lin Tang, Meng Qing Xu, Long Zhang, Lin Qu, Xiaoyan Liu · 2020 · OncoTargets and Therapy
  13. Regulation of ezrin localization by Rac1 and PIPK in human epithelial cells
    Eeva Auvinen, Niina Kivi, Antti I. Vaheri · 2006 · Experimental Cell Research
  14. Tumors of the Skeletal System
    Nicole P. Ehrhart, Neil I. Christensen, Timothy M. Fan · 2019 · Elsevier eBooks
  15. Invasion is a genetic program regulated by transcription factors.
    B. Ozanne, H. Spence, L. Mcgarry, R. Hennigan · 2006 · Current Opinion in Genetics and Development
  16. Depletion of Serum Response Factor by RNA Interference Mimics the Mitogenic Effects of Platelet Derived Growth Factor-BB in Vascular Smooth Muscle Cells
    Nihal Kaplan-Albuquerque, Vicki Van Putten, Mary C.M. Weiser‐Evans, Raphael A. Nemenoff · 2005 · Circulation Research
  17. Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway
    Tielong Liu, Weiwei Zhou, Fei Zhang, Guodong Shi, Honglin Teng, Jianru Xiao, Yan Wang · 2014 · Molecular Medicine Reports
  18. Genetic Factors Conferring Metastasis In Osteosarcoma
    Vadim V Maximov, Rami I. Aqeilan · 2016 · Future Oncology
  19. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process
    Nadia Habel, Bojana Stefanovska, Dimitri Carène, Ana Patiño‐García, Fernando Lecanda, Olivia Fromigué · 2019 · BMC Cancer
  20. Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies
    Courtney R. Schott, Avanthi Tayi Shah, Alejandro Sweet-Cordero · 2020 · Advances in experimental medicine and biology
  21. The Ezrin Metastatic Phenotype Is Associated with the Initiation of Protein Translation
    Joseph Briggs, Ling Ren, Rachel Nguyen, Kristi R. Chakrabarti, Jessica M. Cassavaugh, Said Rahim, Gulay Bulut, Ming Zhou, Timothy D. Veenstra, Qingrong Chen et al. · 2012 · Neoplasia
  22. A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma
    Albert Taiching Liao, Jennifer McCleese, Steven G. Kamerling, James G. Christensen, Cheryl A. London · 2007 · Veterinary and Comparative Oncology
  23. Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium
    Nobuhiko Ohno, Nobuo Terada, Shin-Ichi Murata, Hisashi Yamakawa, Irene Newsham, Ryohei Katoh, Osamu Ohara, Shinichi Ohno · 2004 · Histochemistry and Cell Biology
  24. Expression of Ezrin and Phosphorylated Ezrin (pEzrin) in Pancreatic Ductal Adenocarcinoma
    Yazhou Cui, Tianliang Li, Denglu Zhang, Jinxiang Han · 2010 · Cancer Investigation
  25. Expression and Clinical Significance of Ezrin in Non–Small-Cell Lung Cancer
    Xiaoqin Zhang, Guo-Ping Chen, Tao Wu, Jianping Yan, Jianying Zhou · 2011 · Clinical Lung Cancer
  26. High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma
    Bruno Fuchs, Eric Mahlum, Chandralekha Halder, Avudaippan Maran, Michael J. Yaszemski, Beata Bode, Mark E. Bolander, Gobinda Sarkar · 2007 · Gene
  27. Actin Cytoskeleton Remodelling by Sex Steroids in Neurones
    Angel Matías Sanchez, Marina Inés Flamini, Kinga Polak, Giulia Palla, Stefania Spina, Paolo Mannella, Alessandro David Genazzani, Tommaso Simoncini · 2011 · Journal of Neuroendocrinology
  28. ICAM-2 Expression Mediates a Membrane-Actin Link, Confers a Nonmetastatic Phenotype and Reflects Favorable Tumor Stage or Histology in Neuroblastoma
    Karina Jin Yoon, Doris A. Phelps, Rebecca A. Bush, Joanna S. Remack, Catherine A. Billups, Joseph David Khoury · 2008 · PLoS ONE
  29. Novel targets with potential therapeutic applications in osteosarcoma
    Chand Khanna · 2008 · Current Oncology Reports
  30. Expression of ezrin is associated with invasion and dedifferentiation of hepatitis B related hepatocellular carcinoma
    Chun‐Nan Yeh, See‐Tong Pang, Tsung-Wen Chen, Ren-Ching Wu, Wen‐Hui Weng, Miin-Fu Chen · 2009 · BMC Cancer
  31. Molecular Mechanisms of Canine Osteosarcoma Metastasis
    Sylwia S. Wilk, Katarzyna A. Zabielska-Koczywąs · 2021 · International Journal of Molecular Sciences
  32. Apoptosis Resistance and PKC Signaling: Distinguishing Features of High and Low Metastatic Cells
    Sung-Hyeok Hong, Ling Ren, Arnulfo Mendoza, Ananth S. Eleswarapu, Chand Khanna · 2012 · Neoplasia
  33. Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location
    Yu‐Ching Wei, Chien‐Feng Li, Shih-Chen Yu, Fong‐Fu Chou, Fu-Min Fang, Hock-Liew Eng, Yih‐Huei Uen, Yu-Fang Tian, Jing-Mei Wu, Shau-Hsuan Li et al. · 2009 · Modern Pathology
  34. Expression of Ezrin and Metastatic Tumor Antigen in Osteosarcomas of the Jaw
    Hye‐Rim Park, Romulo Luis Cabrini, Eduardo Santini Araujo, María Luisa Paparella, Daniel Brandizzi, Yong-Koo Park · 2009 · Tumori Journal
  35. Integrin cytoplasmic domain‐associated protein‐1 (ICAP‐1) interacts with the ROCK‐I kinase at the plasma membrane
    Peter J.M. Stroeken, Belén Alvarez, Jacco van Rheenen, Yvonne M. Wijnands, Dirk Geerts, Kees Jalink, Ed Roos · 2006 · Journal of Cellular Physiology
  36. mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells <i>In Vivo</i>
    Morrow, James J., Mendoza, Arnulfo, Koyen, Allyson, Lizardo, Michael M., Ren, Ling, Waybright, Timothy J., Hansen, Ryan J., Gustafson, Daniel L., Zhou, Ming, Fan, Timothy M. et al. · 2016 · Clinical Cancer Research
  37. Targeted Therapy in Bone and Soft Tissue Sarcoma in Children and Adolescents
    Patrick A. Thompson, Murali Chintagumpala · 2012 · Current Oncology Reports
  38. Animal models of osteosarcoma
    Timothy M. Fan · 2010 · Expert Review of Anticancer Therapy
  39. Molecular Alterations Associated with Osteosarcoma Development
    Kosei Ando, Kanji Mori, Franck Verrecchia, Marc Baud’huin, Françoise Rédiní, Dominique Heymann · 2012 · Sarcoma
  40. Ezrin dephosphorylation/downregulation contributes to ursolic acid-mediated cell death in human leukemia cells
    Guobing� Li, T Zhou, L Liu, Jing Chen, Zhicong Zhao, Yongbo Peng, P Li, Ning Gao · 2013 · Blood Cancer Journal
  41. Molecular Biology and Therapeutics in Musculoskeletal Oncology*
    Theresa A. Guise, Regis J. O’Keefe, Robert Lor Randall, Richard M. Terek · 2009 · Journal of Bone and Joint Surgery
  42. Review of management issues in relapsed osteosarcoma
    Vijayamurugan Nataraj, Sameer Bakhshi · 2013 · Expert Review of Anticancer Therapy
  43. How can survival be improved in localized osteosarcoma?
    Dae‐Geun Jeon, Won Seok Song · 2010 · Expert Review of Anticancer Therapy
  44. Bridging the Gap Between Experimental Animals and Humans in Osteosarcoma
    Stephen J. Withrow, Chand Khanna · 2009 · Cancer treatment and research
  45. DISP3 promotes proliferation and delays differentiation of neural progenitor cells
    Martina Zı́ková, Jana Konířová, Karolína Ditrychová, Alicia Corlett, Michal Kolář, Petr Bartůněk · 2014 · FEBS Letters
  46. Biological characterization of preclinical Bioluminescent Osteosarcoma Orthotopic Mouse (BOOM) model: A multi-modality approach
    Rama Garimella, Jeff Daniel Eskew, Priyanka Bhamidi, George A. Vielhauer, Yan Hong, H. Clarke Anderson, Ossama William Tawfik, Peter S. Rowe · 2013 · Journal of bone oncology
  47. Successful identification of a predictive biomarker for lymph node metastasis in colorectal cancer using a proteomic approach
    Koichiro Mori, Yuji Toiyama, Kohei Otake, Shozo Ide, Hiroki Imaoka, Masato Okigami, Yoshinaga Okugawa, Hiroyuki Fujikawa, Susumu Saigusa, Junichiro Hiro et al. · 2017 · Oncotarget
  48. RPN2 Gene Confers Osteosarcoma Cell Malignant Phenotypes and Determines Clinical Prognosis
    Tomohiro Fujiwara, Ryou‐u Takahashi, Nobuyoshi Kosaka, Yutaka Nezu, Akira Kawai, Toshifumi Ozaki, Takahiro Ochiya · 2014 · Molecular Therapy — Nucleic Acids
  49. Re-calculating! Navigating through the osteosarcoma treatment roadblock
    Jeremy McGuire, Thomas J. Utset‐Ward, Damon R. Reed, Conor C. Lynch · 2016 · Pharmacological Research
  50. The clinical significance of the Ezrin gene and circulating tumor cells in osteosarcoma
    Guang‐Xian Zhong, Shaodan Feng, Rongkai Shen, Zhaoyang Wu, Fei Chen, Xia Zhu · 2017 · OncoTargets and Therapy
  51. Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma
    Jared L. Harwood, John H. Alexander, Joel L. Mayerson, Thomas J. Scharschmidt · 2015 · Orthopedic Clinics of North America
  52. Targeting Mechanotransduction in Osteosarcoma: A Comparative Oncology Perspective
    Anita K. Luu, Alicia Viloria‐Petit · 2020 · International Journal of Molecular Sciences
  53. Metastatic Osteosarcoma Gene Expression Differs In Vitro and In Vivo
    Jennifer W. Lisle, Joseph Y. Choi, Jason A. Horton, Matthew J. Allen, Timothy A. Damron · 2008 · Clinical Orthopaedics and Related Research
  54. Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma
    Mikell A. Paige, George W. Kosturko, Güllay Bulut, Matthew Miessau, Said Rahim, Jeffrey A. Toretsky, Milton L. Brown, Aykut Üren · 2013 · Bioorganic & Medicinal Chemistry
  55. Effects of raloxifene on breast cancer cell migration and invasion through the actin cytoskeleton
    Marina Inés Flamini, Xiaodong Fu, Angel Matías Sanchez, Maria Silvia Giretti, Silvia Garibaldi, Lorenzo Goglia, Silvia Pisaneschi, Veronica Tosi, Andrea Riccardo Genazzani, Tommaso Simoncini · 2008 · Journal of Cellular and Molecular Medicine
  56. Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma
    Masahiko Fujiwara, Takeshi G. Kashima, Akiko Kunita, Isao Kii, Daisuke Komura, Agamemnon E. Grigoriadis, Akira Kudō, Hiroyuki Aburatani, Masashi Fukayama · 2011 · Tumor Biology
  57. Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas
    Ana Carneiro, Pär‐Ola Bendahl, Måns Åkerman, Henryk A. Domanski, Anders Rydholm, Jacob Engellau, Mef Christina Nilbert · 2011 · Journal of Clinical Pathology
  58. The Vascular Notch Ligands Delta-Like Ligand 4 (DLL4) and Jagged1 (JAG1) Have Opposing Correlations with Microvascularization but a Uniform Prognostic Effect in Primary Glioblastoma: A Preliminary Study
    Xianxin Qiu, Long Chen, Chenhong Wang, Zhixiong Lin, Bijuan Chen, Na You, Yao Chen, Xingfu Wang · 2015 · World Neurosurgery
  59. Ezrin mediates both HGF/Met autocrine and non‐autocrine signaling‐induced metastasis in melanoma
    Liping Huang, Yifei Qin, Qiang Zuo, Kavita Bhatnagar, Jingbo Xiong, Glenn T Merlino, Yanlin Yu · 2017 · International Journal of Cancer
  60. The Biology of Myxofibrosarcoma: State of the Art and Future Perspectives
    Andrea Sambri, Massimiliano DE PAOLIS, Paolo Spinnato, Davide María Donati, Giuseppe Bianchi · 2020 · Oncology Research and Treatment
  61. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer
    Zhaojin Yu, Mingli Sun, Feng Jin, Qinghuan Xiao, Miao He, Huizhe Wu, Jie Ren, Lin Zhao, Haishan Zhao, Weifan Yao et al. · 2015 · Oncology Reports
  62. Knockdown of Radixin by RNA interference Suppresses the Growth of Human Pancreatic Cancer Cells in Vitro and in Vivo
    Shudong Chen, Mao‐Min Song, Zhiqiang Zhong, Na Li, Pilin Wang, Shi Cheng, Rixing Bai, Hui-Sheng Yuan · 2012 · Asian Pacific Journal of Cancer Prevention
  63. Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling
    Qiyue Chen, Kai Fan, Xi Chen, Xiaobo Xie, Huang Li, Guangbao Song, Weizhong Qi · 2021 · Journal of Cellular and Molecular Medicine
  64. RNAi‐mediated silencing of ezrin gene reverses malignant behavior of human gastric cancer cell line SGC‐7901
    Hong Jian Wang, Jin Zhu, Qiang Zhang, Hua Guo, Yun Dai, Xiao Peng XIONG · 2009 · Journal of Digestive Diseases
  65. Silence of ezrin modifies migration and actin cytoskeleton rearrangements and enhances chemosensitivity of lung cancer cells in vitro
    Qingyong Chen, Wei Xu, Demin Jiao, Lijun Wu, Jia Song, Jie Yan, Jianguo Shi · 2013 · Molecular and Cellular Biochemistry
  66. Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia
    Richard Monni, Lamya Haddaoui, Alexandra Naba, Isabelle Gallais, Monique Arpin, Patrick Mayeux, Françoise Moreau-Gachelin · 2008 · Blood
  67. Altered gene and protein expression by Nm23-H1 in metastasis suppression
    Jong‐Heun Lee, Jean-Claude A. Marshall, Patricia Schriver Steeg, Christine E. Horak · 2009 · Molecular and Cellular Biochemistry
  68. Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy
    Kazuki Heishima, Travis Meuten, Kyoko Yoshida, Takashi Mori, Douglas H. Thamm · 2019 · BMC Veterinary Research
  69. Immunoexpression of Ezrin and CD44 in Patients With Osteosarcoma
    Érica Boldrini, Stela Verzinhasse Peres, Sandra Morini, Beatriz de Camargo · 2010 · Journal of Pediatric Hematology/Oncology
  70. CD44 cross-linking increases malignancy of breast cancer via upregulation of p-Moesin
    Song Nian Hu, Xiaoxing Shi, Yiwen Liu, Yiqing He, Yan Du, Guoliang Zhang, Cuixia Yang, Feng Gao · 2020 · Cancer Cell International
  71. Cell-in-Cell Events in Oral Squamous Cell Carcinoma
    Leonardo de Oliveira Siquara da Rocha, Bruno Solano de Freitas Souza, D Lambert, Clarissa Araújo Gurgel Rocha · 2022 · Frontiers in Oncology
  72. Initiation of malignancy by duodenal contents reflux and the role of ezrin in developing esophageal squamous cell carcinoma
    Zhi‐Qiang Ling, Ken‐ichi Mukaisho, Hiroto Yamamoto, Kuan‐Hao Chen, Shinji Asano, Yoshio Araki, Hiroyuki Sugihara, Weimin Mao, Takanori Hattori · 2009 · Cancer Science
  73. Proximal Tumor Location and Fluid-fluid Levels on MRI Predict Resistance to Chemotherapy in Stage IIB Osteosarcoma
    Dae‐Geun Jeon, Won Seok Song, Wan Hyeong Cho, Chang‐Bae Kong, Sang Hyun Cho · 2014 · Clinical Orthopaedics and Related Research
  74. Clustered phosphatidylinositol 4,5 bisphosphate accumulation and ezrin phosphorylation in response to CLIC5A
    Abass Al-Momany, Laiji Li, Robert Todd Alexander, Barbara J. Ballermann · 2014 · Journal of Cell Science
  75. Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors.
    Eija A. Korkeila, Jari T. T. Sundström, Seppo O Pyrhönen, Kari Juhani Syrjänen · 2011 · PubMed
  76. Expression of c‐FLIP in pulmonary metastases in osteosarcoma patients and human xenografts
    Krithi Rao‐Bindal, Chethan K. Rao, Ling Yu, Eugenie S. Kleinerman · 2012 · Pediatric Blood & Cancer
  77. Nuclear Factor kappa B is central to Marek’s Disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo
    Shyamesh Kumar, Dušan Kunec, Joram Buza, Hsin‐I Chiang, Huaijun Zhou, Sugalesini Subramaniam, Ken Pendarvis, Hans H. Cheng, Shane C. Burgess · 2012 · BMC Systems Biology
  78. Functional genomic analysis of cancer metastasis: biologic insights and clinical implications
    Yibin Kang · 2005 · Expert Review of Molecular Diagnostics
  79. An Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility Genes
    Ling Bai, Howard Hua Yang, Ying Hu, Anjali Shukla, Ngoc‐Han Ha, Anthony Doran, Farhoud Faraji, Natalie E. Goldberger, Maxwell P. Lee, Thomas Keane et al. · 2016 · PLoS Genetics
  80. Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1
    Qu Deng, Ramakrishnan Natesan, Florencia Cidre‐Aranaz, Shehbeel Arif, Ying Liu, Reyaz ur Rasool, Pei Wang, Erick Mitchell-Velasquez, Chandan Kanta Das, Endrit Vinca et al. · 2022 · Cell Reports
  81. ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells
    Ming Ou-Yang, Hongrui Liu, Yu Zhang, Xingang Zhu, Qing Kun Yang · 2011 · Biochimie
  82. Mechanisms of therapy resistance in osteosarcoma: a review
    Jantine PosthumaDeBoer, Barend J. van Royen, Marco N. Helder · 2013 · Oncology Discovery
  83. Moesin–ezrin–radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus
    Hongbo Chen, Lin Mei, Lanzhen Zhou, Xudong Zhang, Caiping Guo, Junchang Li, Huixia Wang, Yongqiang Zhu, Yi Zheng, Laiqiang Huang · 2010 · The International Journal of Biochemistry & Cell Biology
  84. Atypical ezrin localization as a marker of locally advanced breast cancer
    Alan A. Arslan, Deborah Silvera, Rezina Arju, Shah M. Giashuddin, Ilana Belitskaya‐Lévy, Silvia Chiara Formenti, Robert J. Schneider · 2012 · Breast Cancer Research and Treatment
  85. Diagnostic and Prognostic Sarcoma Signatures
    Elai Davicioni, Daniel Wai, Michael J. Anderson · 2008 · Molecular Diagnosis & Therapy
  86. Altered Expression of ezrin, E-Cadherin and β-Catenin in Cervical Neoplasia
    Eeva Auvinen, Olli Carpén, Taina Korpela, Mikko J. Rönty, Antti Vaheri, Jussi Tarkkanen · 2012 · Neoplasma
  87. A summary of the osteosarcoma banking efforts: A report from the Children's Oncology Group and the QuadW Foundation
    Jason Glover, Mark Krailo, Tanya Tello, Neyssa M. Marina, Katherine A. Janeway, Donald A. Barkauskas, Timothy M. Fan, Richard Greg Gorlick, Chand Khanna, the COG Osteosarcoma Biology Group · 2014 · Pediatric Blood & Cancer
  88. Cracking the code: Deciphering the role of the tumor microenvironment in osteosarcoma metastasis
    Jiamin Jin, Jiacheng Cong, Shangbo Lei, Qiujin Zhang, Xinyi Zhong, Yingying Su, Mingchuan Lu, Yifen Ma, Zihe Li, Liyan Wang et al. · 2023 · International Immunopharmacology
  89. Extra-nuclear signaling of ERα to the actin cytoskeleton in the central nervous system
    Angel Matías Sanchez, Tommaso Simoncini · 2009 · Steroids
  90. Clinicopathological significance of podocalyxin and phosphorylated ezrin in uterine endometrioid adenocarcinoma
    Hironao Yasuoka, Masahiko Tsujimoto, Michiya Inagaki, Rieko Kodama, Hiromi Tsuji, Yoshifumi Iwahashi, Yasushi Mabuchi, Kazuhiko Ino, Tokio Sanke, Yasushi K. Nakamura · 2012 · Journal of Clinical Pathology
  91. Knockdown of Radixin Suppresses Gastric Cancer Metastasis In Vitro by Up-Regulation of E-Cadherin via NF-κB/Snail Pathway
    Yuwen Zhu, Junkai Yan, Juanjuan Li, Yang-Ming Ou, Qing Kun Yang · 2016 · Cellular Physiology and Biochemistry
  92. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas
    Yong Chen, Hong-Li Chuan, Shengyuan Yu, Chuzhong Li, Zhe Bao Wu, Guilin Li, Yazhuo Zhang · 2017 · World Neurosurgery
  93. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy
    Yunfei He, Jun Ma, Xiaojian Ye · 2017 · International Journal of Molecular Medicine
  94. A zebrafish embryo screen utilizing gastrulation identifies the HTR2C inhibitor pizotifen as a suppressor of EMT-mediated metastasis
    Joji Nakayama, Lora Tan, Yan Li, Boon Cher Goh, Shu Wang, Hideki Makinoshima, Zhiyuan Gong · 2021 · eLife
  95. Cell cannibalism by malignant neoplastic cells: three cases in dogs and a literature review
    Antonio Meléndez‐Lazo, Paola Cazzini, Melinda S. Camus, G. Doria-Torra, Alberto Marco, Laia Solano‐Gallego, Josep Pastor · 2015 · Veterinary Clinical Pathology
  96. Recent Advances in the Discovery of Biomarkers for Canine Osteosarcoma
    Anita K. Luu, Geoffrey A. Wood, Alicia Viloria‐Petit · 2021 · Frontiers in Veterinary Science
  97. Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway
    Baoshi Yuan, Kexin Shi, Juanmin Zha, Yujia Cai, Yue Gu, Kai Huang, Wenchang Yue, Qiaocheng Zhai, Ning Ding, Wenyan Ren et al. · 2023 · Cell Death and Disease
  98. The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data
    Hongtao Li, Daliu Min, Hui Zhao, Zhiyu Wang, Wei‐Xiang Qi, Shuier Zheng, Lina Tang, Aina He, Yuanjue Sun, Yang Yao et al. · 2013 · PLoS ONE
  99. Targeted therapies in bone sarcomas: current approach and future directions
    Jessica Lee Yarber, Mark Agulnik · 2011 · Expert Opinion on Investigational Drugs
  100. Binding of moesin and ezrin to membranes containing phosphatidylinositol (4,5) bisphosphate: A comparative study of the affinity constants and conformational changes
    Ofélia Maniti, Nada Khalifat, Kriti Goggia, Fabien Dalonneau, Christophe Guérin, Laurent Blanchoin, Laurence Ramos, Catherine Picart · 2012 · Biochimica et Biophysica Acta (BBA) - Biomembranes